Overexpression of HSP60 restricted the release of mitochondrial dsRNA and ameliorated hepatocellular steatosis and liver inflammation in non-alcoholic fatty liver disease in mice [43]. This evidence concerns the gene HSPD1 and metabolic dysfunction-associated steatotic liver disease.